Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy

David S. Goldstein; Courtney Holmes; Oladi Bentho; Takuya Sato; Jeffrey P. Moak; Yehonatan Sharabi; Richard Imrich; Shielah Conant; Basil A. Eldadah

doi:10.1016/j.parkreldis.2008.01.010

Keywords

NeurochemicalAtrophyPutamenParkinson's diseaseInternal medicineDopamineEndocrinologyMedicineNeurodegenerationDopaminergicCerebrospinal fluidSubstantia nigraOlfactionPathologyDiseasePsychologyNeuroscience

Affiliated Institutions

Related Publications

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

H. Bernheimer , W Birkmayer , Oleh Hornykiewicz +2 more

1973 Journal of the Neurological Sciences 2633 citations

Parkinson disease

Roberta Balestrino , Anthony H.V. Schapira

Parkinson disease (PD) is the most common neurodegenerative movement disorder. In Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 000 an...

2019 European Journal of Neurology 1340 citations

New developments in the pathology of Parkinson's disease.

K. A. Jellinger

Recent data on neuronal cytoskeletal pathology of Lewy bodies, a major anatomical hallmark of PD, suggest pathological phosphorylation of neurofilament proteins with ubiquitinat...

1990 PubMed 102 citations

Pathological and clinical features of Parkinson's disease with and without dementia

Rob A. I. de Vos , E.N.H. Jansen , Deniz Yilmazer‐Hanke +2 more

The pathology of Parkinson's disease (PD) is characterized by the presence of neuronal loss, Lewy bodies (LBs), and Lewy neurites (LNs) at predilection sites in the nervous syst...

1996 Cambridge University Press eBooks 9 citations

Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

Angélica Castaño , Antonio J. Herrera , J. Cano +1 more

Abstract: The pathogenesis of Parkinson's disease is still poorly understood. To address the hypothesis that immunemediated events, such as microglial activation, may be involve...

1998 Journal of Neurochemistry 382 citations

Publication Info

Year: 2008
Type: article
Volume: 14
Issue: 8
Pages: 600-607
Citations: 156
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

156

OpenAlex

Cite This

APA Style

                            
                                
                                    David S. Goldstein, 
                                
                                    Courtney Holmes, 
                                
                                    Oladi Bentho
                                
                                et al.
                            
                            (2008). 
                            Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. 
                            Parkinsonism & Related Disorders
                            , 14
                            (8)
                            , 600-607.
                            https://doi.org/10.1016/j.parkreldis.2008.01.010
                        

Identifiers

DOI: 10.1016/j.parkreldis.2008.01.010